These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 38055419)
1. End-to-end validation of fiducial tracking accuracy in robotic radiosurgery using MRI-only simulation imaging. Singhrao K; Zubair M; Nano T; Scholey JE; Descovich M Med Phys; 2024 Jan; 51(1):31-41. PubMed ID: 38055419 [TBL] [Abstract][Full Text] [Related]
2. Accuracy of an MR-only workflow for prostate radiotherapy using semi-automatically burned-in fiducial markers. Goudschaal K; Beeksma F; Boon M; Bijveld M; Visser J; Hinnen K; van Kesteren Z Radiat Oncol; 2021 Feb; 16(1):37. PubMed ID: 33608008 [TBL] [Abstract][Full Text] [Related]
3. Quantification of fiducial marker visibility for MRI-only prostate radiotherapy simulation. Singhrao K; Ruan D; Fu J; Gao Y; Chee G; Yang Y; King C; Hu P; Kishan AU; Lewis JH Phys Med Biol; 2020 Feb; 65(3):035015. PubMed ID: 31881546 [TBL] [Abstract][Full Text] [Related]
4. Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images. Koivula L; Wee L; Korhonen J Med Phys; 2016 Aug; 43(8):4634. PubMed ID: 27487880 [TBL] [Abstract][Full Text] [Related]
5. Evaluating the Hounsfield unit assignment and dose differences between CT-based standard and deep learning-based synthetic CT images for MRI-only radiation therapy of the head and neck. Singhrao K; Dugan CL; Calvin C; Pelayo L; Yom SS; Chan JW; Scholey JE; Singer L J Appl Clin Med Phys; 2024 Jan; 25(1):e14239. PubMed ID: 38128040 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy. Maspero M; Seevinck PR; Willems NJW; Sikkes GG; de Kogel GJ; de Boer HCJ; van der Voort van Zyp JRN; van den Berg CAT Radiat Oncol; 2018 Jun; 13(1):105. PubMed ID: 29871656 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of an automatic MR-based gold fiducial marker localisation method for MR-only prostate radiotherapy. Maspero M; van den Berg CAT; Zijlstra F; Sikkes GG; de Boer HCJ; Meijer GJ; Kerkmeijer LGW; Viergever MA; Lagendijk JJW; Seevinck PR Phys Med Biol; 2017 Oct; 62(20):7981-8002. PubMed ID: 28825917 [TBL] [Abstract][Full Text] [Related]
8. Linac- and CyberKnife-based MRI-only treatment planning of prostate SBRT using an optimized synthetic CT calibration curve. Scholey J; Nano T; Singhrao K; Mohamad O; Singer L; Larson PEZ; Descovich M J Appl Clin Med Phys; 2024 Sep; 25(9):e14411. PubMed ID: 38837851 [TBL] [Abstract][Full Text] [Related]
9. A multi-institutional analysis of a general pelvis continuous Hounsfield unit synthetic CT software for radiotherapy. Yu VY; Keyrilainen J; Suilamo S; Beslimane I; Dresner A; Halkola A; Van der Heide UA; Tyagi N J Appl Clin Med Phys; 2021 Mar; 22(3):207-215. PubMed ID: 33616303 [TBL] [Abstract][Full Text] [Related]
10. A novel anthropomorphic multimodality phantom for MRI-based radiotherapy quality assurance testing. Singhrao K; Fu J; Wu HH; Hu P; Kishan AU; Chin RK; Lewis JH Med Phys; 2020 Apr; 47(4):1443-1451. PubMed ID: 31954078 [TBL] [Abstract][Full Text] [Related]
12. Synthetic digital reconstructed radiographs for MR-only robotic stereotactic radiation therapy: A proof of concept. Szalkowski G; Nie D; Zhu T; Yap PT; Lian J Comput Biol Med; 2021 Nov; 138():104917. PubMed ID: 34688037 [TBL] [Abstract][Full Text] [Related]
13. A generative adversarial network-based (GAN-based) architecture for automatic fiducial marker detection in prostate MRI-only radiotherapy simulation images. Singhrao K; Fu J; Parikh NR; Mikaeilian AG; Ruan D; Kishan AU; Lewis JH Med Phys; 2020 Dec; 47(12):6405-6413. PubMed ID: 32989773 [TBL] [Abstract][Full Text] [Related]
14. Dosimetric and workflow evaluation of first commercial synthetic CT software for clinical use in pelvis. Tyagi N; Fontenla S; Zhang J; Cloutier M; Kadbi M; Mechalakos J; Zelefsky M; Deasy J; Hunt M Phys Med Biol; 2017 Apr; 62(8):2961-2975. PubMed ID: 27983520 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer. De Roover R; Crijns W; Poels K; Peeters R; Draulans C; Haustermans K; Depuydt T Med Phys; 2018 May; 45(5):2205-2217. PubMed ID: 29537613 [TBL] [Abstract][Full Text] [Related]
16. Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging. Osman SOS; Russell E; King RB; Crowther K; Jain S; McGrath C; Hounsell AR; Prise KM; McGarry CK Radiat Oncol; 2019 Dec; 14(1):237. PubMed ID: 31878967 [TBL] [Abstract][Full Text] [Related]